Understanding FDA Breakthrough Therapy Designation for Rare Diseases
Understanding FDA Breakthrough Therapy Designation for Rare Diseases Accelerating Rare Disease Drug Development: FDA Breakthrough Therapy Designation Explained What Is Breakthrough Therapy Designation? The FDA’s Breakthrough Therapy Designation (BTD) is an expedited regulatory pathway created under the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012. It is specifically designed to speed the…
Read More “Understanding FDA Breakthrough Therapy Designation for Rare Diseases” »